# Pacira BioSciences Mails Letter to Stockholders Reiterating Confidence in the Company’s Strategic Direction and Highly Qualified Nominees
Canonical URL: https://biopharmsignal.com/news/PCRX/pacira-biosciences-mails-letter-to-stockholders-reiterating-confidence-in-the-company-s-strategic-direction-and-highly-qualified-nominees
Ticker: PCRX
Company: Pacira BioSciences
Source: Pacira BioSciences
Published: 2026-06-25 13:46 EST
Original Source URL: https://investor.pacira.com
## Summary

Clarifies DOMA’s Inaccuracies and the Reality of Pacira’ Efforts to Strengthen its Market Position Urges Stockholders to Vote “ FOR ” the Election of Pacira’s Highly Qualified Nominees on the BLUE Proxy Card Today BRISBANE, Calif., May 27, 2026 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc.

## Article Body
Clarifies DOMA’s Inaccuracies and the Reality of Pacira’ Efforts to Strengthen its Market Position Urges Stockholders to Vote “ FOR ” the Election of Pacira’s Highly Qualified Nominees on the BLUE Proxy Card Today BRISBANE, Calif., May 27, 2026 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc.
## Recent Company News
- 2026-07-01 12:00 EST — [Pacira BioSciences Announces UnitedHealthcare Now Provides Separate Reimbursement for EXPAREL®](https://biopharmsignal.com/news/PCRX/pacira-biosciences-announces-unitedhealthcare-now-provides-separate-reimbursemen-87b0c6a8) — Source: Pacira BioSciences
- 2026-06-30 11:30 EST — [Pacira BioSciences Announces Agreement to Divest its iovera° Business to Zimmer Biomet](https://biopharmsignal.com/news/PCRX/pacira-biosciences-announces-agreement-to-divest-its-iovera-business-to-zimmer-b-e7793cda) — Source: Pacira BioSciences
- 2026-06-25 13:46 EST — [Pacira BioSciences Announces Stockholders Have Elected All Three of the Company's Director Nominees at Annual Meeting](https://biopharmsignal.com/news/PCRX/pacira-biosciences-announces-stockholders-have-elected-all-three-of-the-company-s-director-nominees-at-annual-meeting) — Source: Pacira BioSciences
- 2026-06-25 13:46 EST — [Pacira BioSciences Reminds Stockholders to Vote the BLUE Proxy Card "FOR" the Election of the Company's Highly Qualified Nominees Ahead of its Annual Meeting](https://biopharmsignal.com/news/PCRX/pacira-biosciences-reminds-stockholders-to-vote-the-blue-proxy-card-for-the-election-of-the-company-s-highly-qualified-nominees-ahead-of-its-annual-meeting) — Source: Pacira BioSciences
- 2026-06-25 13:46 EST — [Pacira BioSciences Highlights Leading Independent Proxy Advisory Firm ISS' Recommendation to Vote "FOR" All of Pacira's Director Nominees](https://biopharmsignal.com/news/PCRX/pacira-biosciences-highlights-leading-independent-proxy-advisory-firm-iss-recommendation-to-vote-for-all-of-pacira-s-director-nominees) — Source: Pacira BioSciences
## Related News
- 2026-07-21 12:00 EST — MOR — [Novartis delivered sales growth in Q2 and further advanced the pipeline; Full-year guidance reaffirmed](https://biopharmsignal.com/news/MOR/novartis-delivered-sales-growth-in-q2-and-further-advanced-the-pipeline-full-yea-63a32b47)
- 2026-07-20 20:05 EST — RANI — [Rani Therapeutics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)](https://biopharmsignal.com/news/RANI/rani-therapeutics-reports-inducement-grant-under-nasdaq-listing-rule-5635-c-4-ec56b3b0)
- 2026-07-20 14:53 EST — IPHA — [Innate Pharma announces Completion of Enrollment in Phase 1 Dose Escalation Study of IPH4502, a Novel Nectin-4 Exatecan Antibody-Drug Conjugate (ADC)](https://biopharmsignal.com/news/IPHA/innate-pharma-announces-completion-of-enrollment-in-phase-1-dose-escalation-stud-0778493f)
- 2026-07-20 13:05 EST — ACAD — [Acadia Pharmaceuticals Receives FDA Fast Track Designation for Remlifanserin in Alzheimer's Disease Psychosis](https://biopharmsignal.com/news/ACAD/acadia-pharmaceuticals-receives-fda-fast-track-designation-for-remlifanserin-in--f36b622c)
- 2026-07-20 13:00 EST — ENLV — [Enlivex Treasury Portfolio Update: NAV Per Ordinary Share $66.16; Total Treasury Holdings Valued at Approximately $1.1 Billion](https://biopharmsignal.com/news/ENLV/enlivex-treasury-portfolio-update-nav-per-ordinary-share-66-16-total-treasury-ho-9d036ef9)